FIELD: medicine.
SUBSTANCE: present invention refers to medicine and can be used for early diagnosis of neurodegenerative diseases, particularly Parkinson's disease, at a pre-symptom (preclinical or prodromal) stage. Diagnostic technique is presented by a method in which an intranasal administration of alpha-methyl-p-tyrosine in the form of a hydrogel suitable for intranasal administration is carried out and a diagnosis of an early stage of Parkinson's disease is detected if observing the symptoms of motor disorders.
EFFECT: disclosed are a pharmaceutical composition based on alpha-methyl-p-tyrosine and a method for early diagnosis of Parkinson's disease.
2 cl, 4 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRECLINICAL DIAGNOSTICS OF PARKINSON'S DISEASE IN PRACTICALLY HEALTHY PERSONS | 2006 |
|
RU2318437C1 |
| PEPTIDE WITH NEUROPROTECTIVE ACTIVITY ON MODEL OF MFTP-INDUCED PARKINSONISM AND A PHARMACEUTICAL COMPOSITION ON ITS BASIS | 2017 |
|
RU2662429C1 |
| METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2722666C1 |
| METHOD FOR EARLY PRECLINICAL DIAGNOSTICS OF PARKINSON'S DISEASE BY CONCENTRATION OF CATECHOLAMINES IN PATIENT'S LACRIMAL FLUID | 2019 |
|
RU2775261C2 |
| DRUG PREPARATION FOR PARKINSON DISEASE | 2014 |
|
RU2545734C1 |
| AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
| METHODS OF PRODUCING N-(4-CHLOROBENZYL)-4-METHOXY-1-(2-METHYLPHENYL)-6-OXO-1,6-DIHYDROPYRIDAZINE-3-CARBOXAMIDE (VERSIONS) | 2018 |
|
RU2694548C1 |
| METHOD OF EARLY PRE-CLINICAL DIAGNOSIS OF PARKINSON'S DISEASE | 2015 |
|
RU2606591C1 |
| PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE | 2012 |
|
RU2618412C2 |
| METHOD OF PARKINSON DISEASE TREATMENT | 1994 |
|
RU2057529C1 |
